1660TiP First-in-human study of ABBV-969, a dual variable antibody-drug conjugate (ADC), in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). - Berger, R.; Tolcher, A.W.; Dorff, T.B.; Okubo, S.; Abraham, L.S.; Reilly, R.; Stevenson, C.; Wang, S.; Arnold, J.; Mudd, S.R.; Alaei, S.; Hong, J.; et al. (Annals of Oncology, 2024)